Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
69.31
+0.58 (0.84%)
At close: Nov 13, 2026, 4:00 PM EST
69.61
+0.30 (0.44%)
After-hours: Nov 13, 2026, 7:58 PM EST
Royalty Pharma Employees
Royalty Pharma had 100 employees as of December 31, 2025. The number of employees increased by 1 or 1.01% compared to the previous year. That makes Royalty Pharma the 31,558th largest employer in the world and 4,046th in the United States.
Employees
100
Change (1Y)
1
Growth (1Y)
1.01%
Revenue / Employee
$26,168,100
Profits / Employee
$6,724,530
Market Cap
39.76B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | 1 | 1.01% |
| Dec 31, 2024 | 99 | 10 | 11.24% |
| Dec 31, 2023 | 89 | 14 | 18.67% |
| Dec 31, 2022 | 75 | 9 | 13.64% |
| Dec 31, 2021 | 66 | 15 | 29.41% |
| Dec 31, 2020 | 51 | 16 | 45.71% |
| Dec 31, 2019 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Genmab | 3,244 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
RPRX News
- 1 day ago - Royalty Pharma to present at the UBS Global Biopharma Conference - GlobeNewsWire
- 8 days ago - Royalty Pharma price target raised to $75 from $67 at Morgan Stanley - TheFly
- 8 days ago - Royalty Pharma Slides: Corporate presentation - Filings
- 8 days ago - Royalty Pharma price target raised to $78 from $70 at Citi - TheFly
- 9 days ago - Royalty Pharma price target raised to $74 from $62 at JPMorgan - TheFly
- 9 days ago - Royalty Pharma Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Royalty Pharma Earnings release: Q3 2026 - Filings
- 9 days ago - Royalty Pharma Slides: Q3 2026 - Filings